Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
OnQuality Pharmaceuticals Ltd. logo — developing innovative drugs and drug delivery systems that i...

OnQuality Pharmaceuticals Ltd.

developing innovative drugs and drug delivery systems that improve the quality of life of oncology patients

Founded 2018 China Shanghai, China 7 employees Series A Total: $35.00M Biopharma, Biotechnology +3

General Information

Company Name OnQuality Pharmaceuticals Ltd.
Founded Year 2018
Location China Shanghai, China
Employees 7
Industries Biopharma, Biotechnology, Health Care +2
Funding Stage Series A
Social

BounceWatch is an independent company data service, not affiliated with OnQuality Pharmaceuticals Ltd.. To contact OnQuality Pharmaceuticals Ltd., visit onqualityrx.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does OnQuality Pharmaceuticals Ltd. compare?

A PDF of OnQuality Pharmaceuticals Ltd. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting OnQuality Pharmaceuticals Ltd. soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About OnQuality Pharmaceuticals Ltd.

OnQuality Pharmaceuticals Ltd. is a healthcare startup based in China, founded in 2018. The company focuses on developing innovative drugs and drug delivery systems that improve the quality of life for oncology patients. With a slogan aiming to improve the lives of cancer patients, OnQuality has made significant strides in this direction.

OnQuality Pharmaceuticals Ltd. has built a substantial pipeline of products to address unmet clinical needs in the area of oncology supportive care. Currently, the company has one asset in Phase II, three in the pre-IND stage, and two others in the early development stage. These developments showcase the company's commitment to advancing cancer care.

The latest milestone in OnQuality's journey is a $20.00M Series A investment at 31 March 2021. The investment was led by a consortium of prominent investors including Matrix Partners China, Sinovation Ventures, BioTrack Capital, Shiyu Capital, Frees Fund, and CASH Capital. This not only underscores the potential and promise of OnQuality Pharmaceuticals but also highlights the confidence of these high-profile investors in the company's mission and approach.

Business keywords: pharmaceuticals, oncology, drug development, drug delivery systems, cancer treatment, innovation, clinical needs, supportive care, pipeline, Phase II, pre-IND stage, early development, commercialization, quality of life

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Series A $20.00M 6
Matrix Partners China Sinovation Ventures BioTrack Capital
Matrix Partners China, Sinovation Ventures +4
31 Mar 2021
Series A $15.00M 3
Matrix Partners China BioTrack Capital
Matrix Partners China, BioTrack Capital +1
28 Oct 2019

OnQuality Pharmaceuticals Ltd. Alternatives & Competitors

View All Alternatives
OnQuality Pharmaceuticals Ltd. vs
Shorla Oncology
Shorla Oncology Ireland

At Shorla Oncology we develop and commercialize innovative oncology medicines for women’s and pediat...

Series B
38 employees
Health Care, Manufacturing
Compare OnQuality Pharmaceuticals Ltd. vs Shorla Oncology
OnQuality Pharmaceuticals Ltd. vs
Adlai Nortye
Adlai Nortye

Pioneering the future of oncology with innovative drug development across the globe.

Post-IPO Equity
51-200 employees
Biotechnology, Health Care
OnQuality Pharmaceuticals Ltd. vs
Rexahn Pharmaceuticals
Rexahn Pharmaceuticals United States

TARGETING DIFFICULT TO TREAT CANCERS

Post-IPO Equity
7 employees
Biotechnology, Medical Devices
Also compare with: OnQuality Pharmaceuticals Ltd. vs OncXerna Therapeutics OncXerna Therapeutics View all alternatives

FAQ About OnQuality Pharmaceuticals Ltd.

developing innovative drugs and drug delivery systems that improve the quality of life of oncology patients
OnQuality Pharmaceuticals Ltd. was founded in 2018.
OnQuality Pharmaceuticals Ltd. is headquartered in Shanghai, China.
OnQuality Pharmaceuticals Ltd. operates in Biopharma, Biotechnology, Health Care, Health and Wellness and Pharmaceutical. Its work centres on pharmaceuticals, oncology, drug development and drug delivery systems.
OnQuality Pharmaceuticals Ltd. has approximately 7 employees.
OnQuality Pharmaceuticals Ltd. has completed 2 funding rounds, raising a total of $35.00M. The latest funding stage is Series A.
Top alternatives and competitors to OnQuality Pharmaceuticals Ltd. include Shorla Oncology, Adlai Nortye, Rexahn Pharmaceuticals, BBB Therapeutics, Biond Biologics Ltd. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
OnQuality Pharmaceuticals Ltd. and Shorla Oncology are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for OnQuality Pharmaceuticals Ltd., https://bouncewatch.com/company/onquality-pharmaceuticals-ltd, updated 24 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout